PANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for PANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for PANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists re-engineer Patients' own cells to hunt advanced cancers
Disease control Recruiting nowThis early-phase study is testing a new type of cell therapy for people with advanced solid tumors, including melanoma, that have spread and are not responding to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack c…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: Anusha Kalbasi • Aim: Disease control
Last updated Apr 01, 2026 18:40 UTC
-
New oral drug trial offers hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing an experimental oral medication called ESK981 for people with advanced pancreatic cancer and certain neuroendocrine cancers that have stopped responding to standard treatments. The trial will enroll 66 patients across three groups to see if taking ESK981 on …
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Can a pill cocktail stop this rare cancer from coming back?
Disease control Recruiting nowThis study is testing whether taking two chemotherapy drugs (capecitabine and temozolomide) after surgery can prevent or delay the return of a rare type of pancreatic cancer called a neuroendocrine tumor in high-risk patients. About 141 adults who have recently had their tumor su…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Major cancer trial tests if aggressive surgery extends life for advanced pancreatic tumors
Disease control Recruiting nowThis study aims to find the best treatment for advanced pancreatic neuroendocrine tumors (NETs) that have spread. It will compare two approaches: one group receives near-total surgical removal of the tumor plus standard drug treatments, while the other receives drug treatments al…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: NA • Sponsor: Uppsala University • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Minimally invasive vs traditional surgery: which is safer for pancreatic cancer?
Disease control Recruiting nowThis study compares two surgical approaches for removing pancreatic and nearby tumors. Researchers want to know if a minimally invasive laparoscopic surgery is as safe and effective as the traditional open surgery. The trial will enroll 90 adult patients with resectable tumors an…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: NA • Sponsor: Minia University • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New pill targets multiple rare cancers in major trial
Disease control Recruiting nowThis study is testing an oral medication called belzutifan for people with advanced rare tumors, including pheochromocytoma, pancreatic neuroendocrine tumors, VHL disease-associated tumors, and certain gastrointestinal cancers. The main goal is to see how well the drug shrinks tu…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New blood test aims to catch deadly pancreatic tumors earlier
Diagnosis Recruiting nowThis study is testing a new blood test that analyzes DNA fragments to try to detect pancreatic neuroendocrine tumors (pNETs) at an early stage. It will involve 1,000 participants who have been diagnosed with specific pancreatic tumors but have not yet started treatment. The goal …
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Fudan University • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
AI vs. doctors: the battle to spot pancreatic cancer
Diagnosis Recruiting nowThis study is testing a new artificial intelligence (AI) system designed to help doctors diagnose and manage pancreatic diseases from CT scans. It will compare the AI's recommendations for surgery or monitoring against the decisions of experienced doctors in 2,000 patients. The m…
Matched conditions: PANCREATIC NEUROENDOCRINE TUMOR
Sponsor: Changhai Hospital • Aim: Diagnosis
Last updated Mar 23, 2026 15:29 UTC